Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Ewha Womans University

Home Clinical Trial Sponsors and OrganizationsEwha Womans University

Ewha Womans University

ACTIVE

首尔特别市, South Koreawww.ewha.ac.krPrivate1,001–5,000 employeesEstablished: 1886-01-01

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

101

6 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

1886

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

70

69.3%

Phase 4

21

20.8%

Phase 2

3

3.0%

Phase 3

1

1.0%

Trial Status Distribution

Active, not recruiting

3

3.0%

Completed

71

70.3%

Not yet recruiting

3

3.0%

Recruiting

15

14.8%

Unknown

5

5.0%

Withdrawn

4

4.0%

Clinical Trials

Trials sponsored by this organization (101)

Human study to evaluate the efficacy and safety of Perilla frutescens and peppermint extract complex on sleep improvement

Jul 202638 participants

Sexuality and Relationship Education for Autistic Adults: Our Love, Our Style

Active, not recruiting

Jul 202690 participants

Evaluation of the efficacy and safety of Policosanol-Sugarcane Wax Alcohols in improving cognitive function

Jul 202672 participants

Effectiveness Verification of an AI Chatbot for Managing Burnout Syndrome among Nursing Staff

Feb 2026148 participants

The Effect of Auricular Acupressure on Wrist Pain, Range of Motion, and Wrist Function in Workers Using Visual Display Terminal

Active, not recruiting

Nov 202564 participants

Development and Feasibility of a Metaverse-based Blended Online Intervention to Prevent Employees' Depression

Jan 202532 participants

Effects of Cervical Sensorimotor Training With Pilates Reformer on Balance and Cervical Joint Position Sense

Sep 202130 participants

Beginning of Effective and Safe Treatment in Immunoglobulin A-1 Nephropathy-1

Jan 2018174 participants

Page 1 of 13

Approvals

No approval data available

News

Chabiotech and Ewha Womans University Launch Government-Backed Project to Develop First-in-Class Autologous Stem Cell Therapy for Peritoneal Fibrosis

- Chabiotech and Ewha Womans University have been selected for a South Korean government-funded project to develop an autologous mesenchymal stem cell-based treatment for peritoneal fibrosis, a life-threatening condition with no existing cure. - The two-year joint research initiative is backed by 235 million won ($163,000) from the Ministry of Science and ICT under the Innovative Postdoctoral Industry-Academia Linkage Project. - The therapy leverages mesenchymal stem cells derived from peritoneal dialysate, which carry a low risk of immune rejection and offer anti-inflammatory and tissue-regeneration properties through a homing effect. - The collaboration aims to complete preclinical trials, establish a GMP-compliant mass-production process, and lay the groundwork for an investigational new drug (IND) application.

On this page

Overview
Clinical Trials101
Approvals
News1

Back to Organizations